Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Oxervate (cenegermin-bkbj) to Treat Neurotrophic Keratitis, US

Oxervate™ (cenegermin-bkbj) is a recombinant human nerve growth factor indicated for the treatment of neurotrophic keratitis. Image courtesy of Dompé.

  • Oxervate™
  • Oxervate™
  • Oxervate™

Go Top